NEU (ASX) NURPF:OTC:PINK Neuren Pharmaceuticals USD $.039 This company specializes in finding treatments for brain trauma, strokes, Alzheimer's and multiple sclerosis using neuroprotection and neuro repair. It currently is conducting stage III trials for its lead drug with the US ARMY researchers at Walter Reed Army Hospital. Any comments about the company would be appreciated. <A HREF="http://www.neurenpharma.com/" target="_blank">http://www.neurenpharma.com/</A> <A HREF="http://www.neurenpharma.com/images/NEU%20Phase%203%20IND%20approval.pdf" target="_blank">http://www.neurenpharma.com/images/NEU%20Phase%203%20IND%20approval.pdf</A> <A HREF="http://www.neurenpharma.com/images/NEU%20Cerebricon%20Study%20Feb%202007.pdf" target="_blank">http://www.neurenpharma.com/images/NEU%20Cerebricon%20Study%20Feb%202007.pdf</A>